Advanced Approaches to Pediatric Fluid and Electrolyte Therapy: What Pharmacists Need to Know

Why It Matters

Adopting isotonic fluids and precise calculation methods reduces life‑threatening electrolyte errors, while pharmacist oversight ensures safe, individualized pediatric care.

Key Takeaways

• Isotonic maintenance IV fluids lower hyponatremia risk
• Holliday‑Segar remains standard; BSA‑based offers alternative
• ORT preferred for mild‑moderate dehydration; IV bolus for severe
• Electrolyte repletion guided by serum levels, renal function, formulation
• Pharmacists monitor fluid volumes, adjust meds, prevent electrolyte shifts

Pulse Analysis

The pediatric fluid landscape has undergone a rapid transformation since the 2018 AAP statement advocated isotonic solutions for children older than 28 days. Multiple randomized trials and meta‑analyses now demonstrate a 60‑70 % reduction in hospital‑acquired hyponatremia when D5NS, lactated Ringer’s, or similar isotonic fluids replace traditional hypotonic regimens. This shift not only improves safety margins but also simplifies electrolyte balancing, as the sodium load aligns with physiologic needs. Hospitals that have updated their order sets report shorter ICU stays and fewer electrolyte‑related interventions, underscoring the clinical and economic payoff of evidence‑based fluid selection.

Accurate maintenance calculations remain the cornerstone of safe rehydration. The classic Holliday‑Segar formula—100 mL per 100 kcal—continues to be taught because of its simplicity and reliable correlation with basal metabolic rate. However, body‑surface‑area (BSA)‑based dosing, typically 1500 mL/m² per day, offers a more nuanced match to energy expenditure, especially in obese or underweight children where caloric assumptions may mislead. Modern pharmacy information systems can automatically pull weight, height, and caloric data to generate both estimates, allowing clinicians to choose the method that best fits the patient’s clinical picture.

Pharmacists are uniquely positioned to translate these fluid and electrolyte principles into bedside practice. By reviewing IV medication volumes, they prevent inadvertent fluid overload and adjust drug concentrations to maintain therapeutic plasma levels despite shifting volume status. Their expertise also guides electrolyte replacement, selecting sodium‑ versus potassium‑phosphate formulations based on concurrent serum potassium, and timing laboratory draws to capture true pharmacodynamic effects. Emerging technologies such as smart infusion pumps with built‑in decision support further amplify the pharmacist’s impact, enabling real‑time alerts for dose limits, incompatibilities, and rapid‑bolus protocols. As pediatric care becomes increasingly data‑driven, the pharmacist’s role in fluid stewardship will only grow.